Literature DB >> 2073122

Fastidious anaerobe agar compared with Wilkins-Chalgren agar, brain heart infusion agar, and brucella agar for susceptibility testing of Fusobacterium species.

J S Brazier1, E J Goldstein, D M Citron, M I Ostovari.   

Abstract

Fastidious anaerobe agar supported the growth of 82 strains of fusobacteria better than brain heart infusion agar, brucella agar, and Wilkins-Chalgren agar. Fastidious anaerobe agar showed less hazing and fewer tailing endpoints with beta-lactam antibiotics. Whole-blood supplementation improved the performance of all media. Wilkins-Chalgren agar without blood failed to support the growth of 17% of the strains. All Fusobacterium ulcerans strains were resistant to clindamycin.

Entities:  

Mesh：

Substances：

Year:  1990        PMID： 2073122      PMCID： PMC172040          DOI： 10.1128/AAC.34.11.2280

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


  4 in total

1.  Cell-wall-defective variants of Fusobacterium.

Authors:  C C Johnson; H M Wexler; S Becker; M Garcia; S M Finegold
Journal:  Antimicrob Agents Chemother       Date:  1989-03       Impact factor: 5.191

2.  Factors affecting antimicrobial susceptibility of Fusobacterium species.

Authors:  M D Rowland; V E Del Bene; J W Lewis
Journal:  J Clin Microbiol       Date:  1987-03       Impact factor: 5.948

Review 3.  Gram-negative anaerobic bacilli: Their role in infection and patterns of susceptibility to antimicrobial agents. II. Little-known Fusobacterium species and miscellaneous genera.

Authors:  W L George; B D Kirby; V L Sutter; D M Citron; S M Finegold
Journal:  Rev Infect Dis       Date:  1981 May-Jun

4.  Recovery of anaerobic bacteria from clinical specimens in 12 years at two military hospitals.

Authors:  I Brook
Journal:  J Clin Microbiol       Date:  1988-06       Impact factor: 5.948
  4 in total
  5 in total

1.  beta-lactamase production and antimicrobial susceptibility of oral heterogeneous Fusobacterium nucleatum populations in young children.

Authors:  E Könönen; A Kanervo; K Salminen; H Jousimies-Somer
Journal:  Antimicrob Agents Chemother       Date:  1999-05       Impact factor: 5.191

2.  Evaluation of the E test for susceptibility testing of anaerobic bacteria.

Authors:  D M Citron; M I Ostovari; A Karlsson; E J Goldstein
Journal:  J Clin Microbiol       Date:  1991-10       Impact factor: 5.948

3.  Antimicrobial susceptibility testing of Bilophila wadsworthia by using triphenyltetrazolium chloride to facilitate endpoint determination.

Authors:  P Summanen; H M Wexler; S M Finegold
Journal:  Antimicrob Agents Chemother       Date:  1992-08       Impact factor: 5.191

4.  Clinical Differences in Patients Infected with Fusobacterium and Antimicrobial Susceptibility of Fusobacterium Isolates Recovered at a Tertiary-Care Hospital in Korea.

Authors:  Myungsook Kim; Shin Young Yun; Yunhee Lee; Hyukmin Lee; Dongeun Yong; Kyungwon Lee
Journal:  Ann Lab Med       Date:  2022-03-01       Impact factor: 3.464

5.  In Vitro and In Silico Based Approaches to Identify Potential Novel Bacteriocins from the Athlete Gut Microbiome of an Elite Athlete Cohort.

Authors:  Laura Wosinska; Calum J Walsh; Paula M O'Connor; Elaine M Lawton; Paul D Cotter; Caitriona M Guinane; Orla O'Sullivan
Journal:  Microorganisms       Date:  2022-03-24
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.